When drug trials go awry
Broadcast: Midmorning, 09/01/2010, 9:06 a.m.
Over the past few years, pharmaceutical research has become more commercialized and market-driven. For two bioethicists, that raises questions about the quality of the data in drug trials, and the safety of the participants in those trials.
- Carl Elliott: Professor in the Center for Bioethics at the University of Minnesota. He is the author of "White Coat, Black Hat: Adventures on the Dark Side of Medicine."
- Howard Brody: Director of the Institute for the Medical Humanities.